Skip to main content

Anthony Caruso, Thomas Klaue

Anthony Caruso has joined Febit as vice president of informatics and application software, the firm said last week. Caruso’s responsibilities include the guidance of the company’s application development and supporting Febit's US customer base.
Prior to joining Febit, Caruso was president and founder of Source Code Genetics, an informatics consulting company focusing on decision support, data mining, and data management. In the past he also held similar positions at Lion Bioscience, Altana Pharma, and Genome Therapeutics.

Thomas Klaue has been named chief financial officer at MediGene, the firm said last week. He will assume his duties effective June 15.
Klaue is currently a partner at Fozzati Partners, a private investment bank in Frankfurt, Germany. He previously served as vice president of business development at Infineon Technologies where he helped establish its biochip business.
Klaue holds degrees in management education from the Massachusetts Institute of Technology and Harvard Business School.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.